Klaria Pharma Holding Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Public

  • Employees
  • 4

Employees

  • Stock Symbol
  • KLAR

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $0.04
  • (As of Wednesday Closing)

Klaria Pharma Holding General Information

Description

Klaria Pharma Holding AB is a Swedish pharmaceutical company that develops rapid-acting products. By combining patented technology of a film that attaches to the oral mucosa and pharmaceuticals, the company has developed a drug distribution concept with many benefits and potential uses. Its patented drug delivery platform consists of an alginate-based polymer film that enables the absorption of a product's active substance through the oral mucosa.

Contact Information

Website
www.klaria.com
Formerly Known As
Annodam AB
Ownership Status
Publicly Held
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • Virdings Allé 2
  • 754 50 Uppsala
  • Sweden
+46 08-446
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Stock Exchange
STO
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Virdings Allé 2
  • 754 50 Uppsala
  • Sweden
+46 08-446

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Klaria Pharma Holding Stock Performance

As of 18-Jun-2025, Klaria Pharma Holding’s stock price is $0.04. Its current market cap is $6.36M with 149M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.04 $0.04 $0.02 - $0.17 $6.36M 149M 507K -$0.04

Klaria Pharma Holding Financials Summary

As of 31-Dec-2024, Klaria Pharma Holding has a trailing 12-month revenue of $213K.

In Thousands,
USD 		TTM 31-Dec-2024 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 3,886 3,886 4,715 5,847
Revenue 213 213 795 578
EBITDA (1,904) (1,904) (1,990) (4,416)
Net Income (4,515) (4,515) (3,367) (6,286)
Total Assets 5,190 5,190 7,299 11,529
Total Debt 2,091 2,091 1,929 1,638
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Klaria Pharma Holding Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Klaria Pharma Holding‘s full profile, request access.

Request a free trial

Klaria Pharma Holding Patents

  • 57

    Total Documents Applications and Grants

  • Total Patents Families

  • 21

    Granted

  • 15

    Pending

  • Expiring in next 12 mo

Klaria Pharma Holding Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201912505-D0 Pharmaceutical formulation Inactive 30-Aug-2019
AU-2020338697-A1 Pharmaceutical formulation Inactive 30-Aug-2019
EP-4021405-A1 Pharmaceutical formulation Active 30-Aug-2019
US-20220280453-A1 Pharmaceutical formulation Pending 30-Aug-2019
CA-3146475-A1 Pharmaceutical formulation Pending 30-Aug-2019 A61K9/7007
To view Klaria Pharma Holding’s complete patent history, request access »

Klaria Pharma Holding Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Klaria Pharma Holding Acquisitions (3)

Klaria Pharma Holding’s most recent deal was a Merger/Acquisition with Karessa Pharma Holding for . The deal was made on 06-Mar-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Karessa Pharma Holding 06-Mar-2020 Merger/Acquisition Drug Delivery
Uppsalagruppen Medical 05-Nov-2019 Merger/Acquisition Drug Delivery
WBC Technologies 19-Sep-2019 Merger/Acquisition Drug Delivery
To view Klaria Pharma Holding’s complete acquisitions history, request access »

Klaria Pharma Holding Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
WBC Technologies Munich, Germany 2019
Uppsalagruppen Medical Uppsala, Sweden 2011

Klaria Pharma Holding FAQs

  • When was Klaria Pharma Holding founded?

    Klaria Pharma Holding was founded in 2015.

  • Where is Klaria Pharma Holding headquartered?

    Klaria Pharma Holding is headquartered in Uppsala, Sweden.

  • What is the size of Klaria Pharma Holding?

    Klaria Pharma Holding has 4 total employees.

  • What industry is Klaria Pharma Holding in?

    Klaria Pharma Holding’s primary industry is Drug Delivery.

  • Is Klaria Pharma Holding a private or public company?

    Klaria Pharma Holding is a Public company.

  • What is Klaria Pharma Holding’s stock symbol?

    The ticker symbol for Klaria Pharma Holding is KLAR.

  • What is the current stock price of Klaria Pharma Holding?

    As of 18-Jun-2025 the stock price of Klaria Pharma Holding is $0.04.

  • What is the current market cap of Klaria Pharma Holding?

    The current market capitalization of Klaria Pharma Holding is $6.36M.

  • What is Klaria Pharma Holding’s current revenue?

    The trailing twelve month revenue for Klaria Pharma Holding is $213K.

  • What is Klaria Pharma Holding’s annual earnings per share (EPS)?

    Klaria Pharma Holding’s EPS for 12 months was -$0.04.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »